Journal article icon

Journal article

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Abstract:

BACKGROUND: Neutralization of tumor necrosis factor a (TNF-alpha) for three to six months reduces the symptoms and signs of rheumatoid arthritis. However, the capacity of this approach to effect a more sustained benefit and its effect on joint damage are not known. METHODS: We treated 428 patients who had active rheumatoid arthritis despite methotrexate therapy with placebo or infliximab, a chimeric monoclonal antibody against TNF-alpha, in intravenous doses of 3 or 10 mg per kilogram of bod...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1056/nejm200011303432202

Authors


Expand authors...
Journal:
The New England journal of medicine
Volume:
343
Issue:
22
Pages:
1594-1602
Publication date:
2000-11-05
DOI:
EISSN:
1533-4406
ISSN:
0028-4793
URN:
uuid:cdbf7087-221d-4de1-815f-fac0406ebc0d
Source identifiers:
224268
Local pid:
pubs:224268

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP